Add-on Acquisition • Life Science

Revvity Acquires Chemagen Biopolymer-Technologie AG

On February 14, 2011, Revvity acquired life science company Chemagen Biopolymer-Technologie AG

Acquisition Context

This is Revvity’s 3rd transaction in the Life Science sector.
This is Revvity’s 2nd transaction in Germany.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	February 14, 2011
Target	Chemagen Biopolymer-Technologie AG
Sector	Life Science
Buyer(s)	Revvity
Deal Type	Add-on Acquisition
Advisor(s)	Mummert & Company Corporate Finance GmbH (Financial)

Target Company

Chemagen Biopolymer-Technologie AG

Baesweiler, Germany

chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company’s strategy to advance its offerings to the molecular diagnostics and research markets.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Revvity

Waltham, Massachusetts, United States

Category	Company
Founded	1937
Sector	Medical Products
Employees	11,000
Revenue	2.8B USD (2024)

DESCRIPTION

Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formed in 1937 and is based in Waltham, Massachusetts.

Deal Context for Buyer	#
Overall	17 of 37
Sector: Life Science	3 of 8
Type: Add-on Acquisition	15 of 35
Country: Germany	2 of 4
Year: 2011	1 of 6

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2010-11-29	Excelitas Technologies Waltham, Massachusetts, United States Excelitas Technologies is a global provider of photonics technology solutions. The Company’s components, modules and sub-systems enable its customers to develop unique, technology-driven products that serve a broad range of growing end markets. Excelitas’ core capabilities include expertise in detection, optics, illumination and advanced electronics. The Company primarily targets high-growth applications within the life sciences, industrial, semiconductor, consumer and defense and aerospace markets. Excelitas Technologies was founded in 1931 and is based in Waltham, Massachusetts.	Sell	$500M

DATE

TARGET

DEAL TYPE

VALUE

2010-11-29

Excelitas Technologies

Waltham, Massachusetts, United States

Excelitas Technologies is a global provider of photonics technology solutions. The Company’s components, modules and sub-systems enable its customers to develop unique, technology-driven products that serve a broad range of growing end markets. Excelitas’ core capabilities include expertise in detection, optics, illumination and advanced electronics. The Company primarily targets high-growth applications within the life sciences, industrial, semiconductor, consumer and defense and aerospace markets. Excelitas Technologies was founded in 1931 and is based in Waltham, Massachusetts.

Sell

$500M

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2011-03-24	CambridgeSoft Cambridge,, Massachusetts, United States CambridgeSoft Corporation provides software services to life science.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2011-03-24

CambridgeSoft

Cambridge,, Massachusetts, United States

CambridgeSoft Corporation provides software services to life science.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Germany M&A - 2011 M&A